Invention Grant
- Patent Title: Engineered ketoreductase polypeptides
-
Application No.: US15982291Application Date: 2018-05-17
-
Publication No.: US10752926B2Publication Date: 2020-08-25
- Inventor: Christopher Savile , John M. Gruber , Emily Mundorff , Gjalt W. Huisman , Steven J. Collier
- Applicant: Codexis, Inc.
- Applicant Address: US CA Redwood City
- Assignee: Codexis, Inc.
- Current Assignee: Codexis, Inc.
- Current Assignee Address: US CA Redwood City
- Agency: Codexis, Inc.
- Main IPC: C12P17/00
- IPC: C12P17/00 ; C12N9/04 ; C12P13/00

Abstract:
The present disclosure provides engineered ketoreductase enzymes having improved properties as compared to a naturally occurring wild-type ketoreductase enzyme. Also provided are polynucleotides encoding the engineered ketoreductase enzymes, host cells capable of expressing the engineered ketoreductase enzymes, and methods of using the engineered ketoreductase enzymes to synthesize a variety of chiral compounds. The engineered ketoreductase polypeptides are optimized for catalyzing the conversion of N-methyl-3-keto-3-(2-thienyl)-1-propanamine to (S)—N-methyl-3-hydroxy-3-(2-thienyl)-1-propanamine.
Public/Granted literature
- US20180251802A1 ENGINEERED KETOREDUCTASE POLYPEPTIDES Public/Granted day:2018-09-06
Information query